CVVHD results in longer filter life than pre-filter CVVH: Results of a quasi-randomized clinical trial

BACKGROUND: Filter clotting is a major issue in continuous kidney replacement therapy (CKRT) that interrupts treatment, reduces delivered effluent dose, and increases cost of care. While a number of variables are involved in filter life, treatment modality is an understudied factor. We hypothesized...

Descripción completa

Detalles Bibliográficos
Autores principales: Mann, Lewis, Ten Eyck, Patrick, Wu, Chaorong, Story, Maria, Jenigiri, Sree, Patel, Jayesh, Honkanen, Iiro, O’Connor, Kandi, Tener, Janis, Sambharia, Meenakshi, Fraer, Mony, Nourredine, Lama, Somers, Douglas, Nizar, Jonathan, Antes, Lisa, Kuppachi, Sarat, Swee, Melissa, Kuo, Elizabeth, Huang, Chou-Long, Jalal, Diana I., Griffin, Benjamin R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9833553/
https://www.ncbi.nlm.nih.gov/pubmed/36630406
http://dx.doi.org/10.1371/journal.pone.0278550

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9833553/
https://www.ncbi.nlm.nih.gov/pubmed/36630406
http://dx.doi.org/10.1371/journal.pone.0278550

Ejemplares similares